JPH0564949B2 - - Google Patents

Info

Publication number
JPH0564949B2
JPH0564949B2 JP61088384A JP8838486A JPH0564949B2 JP H0564949 B2 JPH0564949 B2 JP H0564949B2 JP 61088384 A JP61088384 A JP 61088384A JP 8838486 A JP8838486 A JP 8838486A JP H0564949 B2 JPH0564949 B2 JP H0564949B2
Authority
JP
Japan
Prior art keywords
triazole
formula
fluorobenzyl
difluorobenzyl
dicarboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61088384A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61243068A (ja
Inventor
Maiaa Reene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS61243068A publication Critical patent/JPS61243068A/ja
Publication of JPH0564949B2 publication Critical patent/JPH0564949B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP61088384A 1985-04-18 1986-04-18 フッ素化１―ベンジル―１ｈ―１，２，３―トリアゾール化合物及びそれを含有する抗痙攣剤 Granted JPS61243068A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH166385 1985-04-18
CH1663/85-5 1985-04-18

Publications (2)

Publication Number Publication Date
JPS61243068A JPS61243068A (ja) 1986-10-29
JPH0564949B2 true JPH0564949B2 (enExample) 1993-09-16

Family

ID=4215715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61088384A Granted JPS61243068A (ja) 1985-04-18 1986-04-18 フッ素化１―ベンジル―１ｈ―１，２，３―トリアゾール化合物及びそれを含有する抗痙攣剤

Country Status (22)

Country Link
EP (1) EP0199262B1 (enExample)
JP (1) JPS61243068A (enExample)
KR (1) KR900008810B1 (enExample)
AU (1) AU599024B2 (enExample)
CA (1) CA1272201A (enExample)
CY (1) CY1751A (enExample)
DD (1) DD245874A5 (enExample)
DE (1) DE3677626D1 (enExample)
DK (1) DK169720B1 (enExample)
ES (2) ES8800176A1 (enExample)
FI (1) FI93544C (enExample)
GR (1) GR861004B (enExample)
HK (1) HK1494A (enExample)
HU (1) HU203327B (enExample)
IE (1) IE58472B1 (enExample)
IL (1) IL78510A (enExample)
MX (1) MX9203628A (enExample)
NO (1) NO164295C (enExample)
NZ (1) NZ215871A (enExample)
PH (1) PH22568A (enExample)
PT (1) PT82400B (enExample)
ZA (1) ZA862873B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3578499D1 (de) * 1984-02-02 1990-08-09 Merck & Co Inc 5-(amino oder substituiertes amino)-1,2,3-triazole.
AU2633897A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Solid phase and combinatorial synthesis of substituted 1,2,3-triazoles and of arrays of substituted 1,2,3-triazoles
PL189232B1 (pl) 1996-07-11 2005-07-29 Novartis Ag Sposób wytwarzania 1-podstawionych 4-cyjano-1,2,3-triazoli
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
TW513301B (en) * 1999-03-01 2002-12-11 Novartis Ag Pharmaceutical composition for treatment of neuropathic pain and affective and attention disorders
WO2004106329A2 (en) * 2003-06-03 2004-12-09 Dr. Reddy's Laboratories Ltd. Novel antiinfective compounds and their pharmaceutical compositions
IT1393368B1 (it) * 2009-03-23 2012-04-20 Dipharma Francis Srl Metodo per la preparazione di rufinamide
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
JP2013525413A (ja) * 2010-04-30 2013-06-20 ラボラトリオス レスヴィ，エス．エル． ルフィナマイド中間体の改良された製造方法
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014120994A1 (en) * 2013-01-31 2014-08-07 The Johns Hopkins University Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
US9771335B2 (en) * 2015-07-31 2017-09-26 The Johns Hopkins University Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
US12023322B2 (en) 2015-12-11 2024-07-02 Aarhus Universitet Rufinamide for use in the treatment of myotonia
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide
CN116874438A (zh) * 2023-06-02 2023-10-13 大连理工大学 一锅法制备多取代1,2,3-三唑类化合物
CN116854644B (zh) * 2023-07-06 2025-10-21 浙江大学 5-氨基-1-烷基-1h-1,2,3-三氮唑-4-甲酰胺类化合物及其制备和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
FI834666A7 (fi) * 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.

Also Published As

Publication number Publication date
HUT40792A (en) 1987-02-27
GR861004B (en) 1986-08-12
IL78510A0 (en) 1986-08-31
JPS61243068A (ja) 1986-10-29
PT82400B (pt) 1988-08-17
ES8800176A1 (es) 1987-10-16
NZ215871A (en) 1989-01-27
FI93544B (fi) 1995-01-13
DK169720B1 (da) 1995-01-23
FI93544C (fi) 1995-04-25
EP0199262A2 (de) 1986-10-29
AU599024B2 (en) 1990-07-12
HU203327B (en) 1991-07-29
CY1751A (en) 1994-06-03
NO861486L (no) 1986-10-20
KR900008810B1 (ko) 1990-11-30
IE861015L (en) 1986-10-18
DK175686A (da) 1986-10-19
HK1494A (en) 1994-01-14
EP0199262B1 (de) 1991-02-27
FI861573A0 (fi) 1986-04-14
ES8802501A1 (es) 1988-07-01
ES557641A0 (es) 1988-07-01
PH22568A (en) 1988-10-17
DD245874A5 (de) 1987-05-20
KR860008152A (ko) 1986-11-12
NO164295C (no) 1990-09-19
PT82400A (en) 1986-05-01
IE58472B1 (en) 1993-09-22
NO164295B (no) 1990-06-11
IL78510A (en) 1992-05-25
ES554024A0 (es) 1987-10-16
CA1272201A (en) 1990-07-31
DE3677626D1 (de) 1991-04-04
DK175686D0 (da) 1986-04-17
MX9203628A (es) 1992-09-01
EP0199262A3 (en) 1987-08-26
ZA862873B (en) 1986-12-30
AU5631986A (en) 1986-10-23
FI861573A7 (fi) 1986-10-19

Similar Documents

Publication Publication Date Title
JPH0564949B2 (enExample)
JP5269798B2 (ja) トリチルオルメサルタンメドキソミルおよびオルメサルタンメドキソミルの製造方法
EP0124476B1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
JP2004524358A (ja) フェニル酢酸誘導体の製造方法
JP4838924B2 (ja) ２−クロロ−５−クロロメチルチアゾールの製造方法
KR101502322B1 (ko) 순수한 아나스트로졸의 제조방법
EP2945946A1 (en) Process for the preparation and purification of apixaban
CN101107228B (zh) (z)-1-苯基-1-(n,n-二乙氨基羰基)-2-邻苯二甲酰亚氨甲基环丙烷的制造方法
JPS59118775A (ja) アラルキルトリアゾ−ル化合物
KR900008133B1 (ko) 벤즈아미드의 제조방법
EP3281941B1 (en) Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
US8288561B2 (en) Process for preparing valsartan
KR100254710B1 (ko) 카르바모일유도체,이것을 함유하는 약학적 조성물 및 이들의 제조방법
JPH06340622A (ja) ベンジルコハク酸誘導体の製造方法およびその製造中間体
Liu et al. Novel fused heterocycles: Synthesis and activity of 5, 6-dihydro-7-thia-1, 3, 3a, 5-tetraazainden-4-one and 1-thia-3, 4a, 9-triazafluoren-4-one derivatives
JPH07242670A (ja) ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤
JPH0441481A (ja) イミダゾール類のハロゲン化方法
JP2010526126A (ja) バルサルタンの製造方法
NO145274B (no) Fremgangsmaate for fremstilling av et 1-benzoyl-2-(2`,6`-diklorfenylamino)-2-imidazolin og av deres salter
JPH0457662B2 (enExample)
JPH0481579B2 (enExample)
JPH0244466B2 (enExample)
HK1172906A1 (en) Process for the manufacture of pharmaceutically active compounds
HK1172906B (en) Process for the manufacture of pharmaceutically active compounds
JPH09176129A (ja) ２−アルキル−４−クロロ−５−ヒドロキシメチルイミダゾール誘導体の製造法

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term